Protein Changes in Parkinson's Disease and L-DOPA Treatment
Author Information
Author(s): Kultima Kim, Scholz Birger, Alm Henrik, Sköld Karl, Svensson Marcus, Crossman Alan R, Bezard Erwan, Andrén Per E, Lönnstedt Ingrid
Primary Institution: Uppsala University
Hypothesis
Can different normalization methods effectively remove bias in 2D-DIGE data from a Parkinson's disease model?
Conclusion
The study identifies specific protein sets affected by L-DOPA treatment in a Parkinson's disease model and recommends effective normalization methods.
Supporting Evidence
- Two normalization methods effectively removed both intensity and spatial bias.
- Protein sets associated with energy metabolism were identified as affected by L-DOPA.
- Methodological recommendations were made based on the analysis of different normalization techniques.
Takeaway
Researchers looked at how proteins change in monkeys with Parkinson's disease when treated with L-DOPA, finding some methods to better analyze the data.
Methodology
The study used 2D-DIGE to analyze protein content in the striatum of monkeys, comparing different normalization methods to remove bias.
Potential Biases
There is a risk of bias due to the nature of the data and the normalization methods used.
Limitations
The study's conclusions may be limited by the complexity of protein modifications and the potential for bias in the data.
Participant Demographics
27 female monkeys (Macaca fascicularis), average age 4.4 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website